In the BioHarmony Drug Report Database
Argatroban
Argatroban (argatroban) is a small molecule pharmaceutical. Argatroban was first approved as Argatroban on 2000-06-30. It is used to treat thrombocytopenia and thromboembolism in the USA. The pharmaceutical is active against prothrombin. Argatroban’s patent is valid until 2027-09-26 (FDA).
Trade Name
|
Argatroban |
|---|---|
Common Name
|
argatroban |
ChEMBL ID
|
CHEMBL1166 |
Indication
|
thrombocytopenia, thromboembolism |
Drug Class
|
Antithrombotics (thromboxane A2 receptor antagonists) |
Image (chem structure or protein)